
Pharmacally
Esophageal Cancers
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Esophageal Cancers
Clinical TrialsIza-bren Extends Survival in Phase 3 Trials Across Triple-Negative Breast and Esophageal CancersSystImmune and Bristol Myers Squibb reported positive Phase 3 results for izalontamab brengitecan (iza‑bren), demonstrating significant improvements in overall and progression‑free survival in advanced triple‑negative breast cancer and…Fact-Checked
New Drug ApprovalHenlius Secures EU Approval for Serplulimab in Lung and Esophageal CancersHenlius secured European Commission approval for serplulimab in first-line non-squamous NSCLC and PD-L1-positive ESCC, expanding the anti-PD-1 therapy’s oncology footprint in Europe.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.